Blood Test Could Catch Early Pancreatic Cancer
This article is based upon a Johns Hopkins Medicine press release on October 23, 2013. Initial study results are encouraging, but needs to duplicate the initial results in a larger
Scripps Genomic Medicine Award Given To Dr. Daniel Von Hoff
Matching Genetic Makeup To Provide The Best Quality of Life. March, 2011. Dr. Daniel Von Hoff was presented the Scripps Genomic Medicine Award which recognizes his “pioneering efforts” in sequencing,
Abraxane (Nab-Paclitaxel) Acts Like a Trojan Horse To Extend Life of Late Stage Pancreatic Cancer Patients
Based on the original press release October 16, 2013. Seena Magowitz Foundation is very pleased to make this announcement. According to Dr. Daniel Von Hoff, “We are very grateful to
Dr. Daniel Von Hoff Inducted Into
Joshua Lederberg Society
Based on the original press Release February 13, 2014. Seena Magowitz Foundation is proud to announce that Dr. Von Hoff has been inducted into the Joshua Lederberg Society for his NAPOLI-1 Phase 3 Clinical Trial
Based upon original press release of June 3, 2014. A clinical trial conducted by researchers at the Virginia G. Piper Cancer Center Clinical Trials, a partnership between Scottsdale Healthcare and
Long Term Use of Aspirin May Reduce Risk For Pancreatic Cancer
Press Release: June 26, 2014 Article Submission: Renee Elizabeth Gaudette Continual use of low-dose or regular-dose aspirin may cut a person’s risk of developing pancreatic cancer in half, a Yale
Pancreatic Cancer Vaccine Study Hopes To Improve Treatment
June 12, 2014: TGen, Scottsdale Healthcare and Virginia G. Piper Leads Unprecedented Clinical Trial. Medical investigators at the Virginia G. Piper Cancer Center at Scottsdale Healthcare are studying a new
Metformin Reduces Risk of Pancreatic Cancer
University of Texas M.D. Anderson Center Research Suggests That The Anti-Diabetic Drug, Metformin Reduces The Risk of Type 2 Diabetes Patients of Developing Pancreatic Cancer by 62%. August 1, 2009